MongoDB Inc. diskutieren
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $325.00 to $280.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $270.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "buy" rating re-affirmed by analysts at Tigress Financial. They now have a $365.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Piper Sandler from $400.00 to $425.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Needham & Company LLC from $430.00 to $445.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Oppenheimer Holdings Inc. from $430.00 to $480.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $445.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Argus from $435.00 to $484.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Tigress Financial from $490.00 to $495.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $450.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target lowered by analysts at KeyCorp from $495.00 to $440.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) was upgraded by analysts at Capital One Financial Co. from an "equal weight" rating to an "overweight" rating. They now have a $427.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $430.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $500.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $450.00 price target on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Royal Bank of Canada from $445.00 to $475.00. They now have an "outperform" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Piper Sandler from $425.00 to $500.00. They now have an "overweight" rating on the stock.
Ratings data for MDB provided by MarketBeat
MongoDB, Inc. (NASDAQ: MDB) had its price target raised by analysts at Needham & Company LLC from $445.00 to $495.00. They now have a "buy" rating on the stock.
Ratings data for MDB provided by MarketBeat
Neueste Beiträge
Canaccord_Genuity_Gr in Ultragenyx Pharmaceutical Inc. diskutieren